Management team of experienced biotech professionals

A team dedicated to bringing eTheRNA’s multiple mRNA platforms to the next level.

Steven Powell

CEO

Steven Powell

Steven is a Ph.D. microbiologist with Large Cap Pharma experience. He was a former CEO of both public and private biotech companies. He was previously a partner at Glide Healthcare Partners.

Bernard Sagaert

Senior VP, COO

Bernard Sagaert

Bernard is an Industrial Pharmacist with extensive experience in the pharmaceutical industry. He has expertise in pharmaceutical authorizations, inspections and manufacturing. He was a former QA & Supply Chain Director at Mylan in Belgium.

Mathieu Lane

CFO and President of eTheRNA Inc.

Mathieu Lane

Mathieu has over 15 years of experience in healthcare investment banking at Guggenheim Securities and Bear Stearns. He previously worked in lipid-based gene-therapy at Genzyme. He also has venture experience at SR One.

Michael Mulqueen

VP Business Development

Michael Mulqueen

Michael has over 30 years of experience in the Pharma and biotech industry, including 18 years in business development. He served as Head of Business Development & Licensing at Silence Therapeutics. He has held prior business development roles at Roche, Biotie Therapies and Synosia Therapeutics.

Volker Germaschewski

Senior VP R&D

Volker Germaschewski

Volker has over 20 years of R&D experience in the pharmaceutical industry. Prior to joining eTheRNA, he spent 10 years across hematology and antibody discovery at Kymab (UK). He also spent 10 years in R&D at GSK.

Stefaan De Koker

VP Discovery

Stefaan De Koker

Stefaan is Principal Scientist with over 15 years of research experience in immunology, immuno-oncology, vaccine design and nucleic acid delivery. He has a publication track record of over >50 publications and is the key author of a number of patents.

Diane Van Hoorick

VP Translational Development

Diane Van Hoorick

Diane is a molecular biophysicist with over 10 years of experience in pharmaceutical R&D; from drug discovery to clinical development. Before joining eTheRNA, Diane held the position of Head of immune oncology project management at Ablynx, Sanofi.

Marina Cools

VP Clinical Development

Marina Cools

Marina is a virologist with over twenty years of experience in pharmaceutical R&D; from drug discovery to late stage clinical development. She has worked with biotech SMEs and large pharmaceutical companies.

Phil Challis

VP Product Development

Phil Challis

Phil has 30 years of experience in the Pharmaceutical and Biotech industry having worked for small SME’s, larger pharmaceutical companies and CDMO’s. He has broad experience in manufacture of biologicals and NCE’s with experience in transfer of processes from R&D, process development through clinical phases and process validation and commercial manufacture.

Dirk Van Broekhoven

VP Corporate Management, General Counsel

Dirk Van Broekhoven

Dirk has more than twenty-five years of experience as legal counsel in the healthcare industry. In addition to his general legal, he has specialized in intellectual property management and corporate development and licensing.